Praneet Kaki
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (23)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Objective This pilot study aims to demonstrate the feasibility of continuous sleep monitoring using the Withings Sleep Mat (WSM) and to illustrate Mean Disease Alleviation (MDA) as a potential metric for assessing real‐world treatment effectiveness among patients with obstructive sleep apnea (OSA) treated with hypoglossal nerve stimulation (HGNS) or continuous positive airway pressure (CPAP). Methods Patients treated with CPAP or HGNS therapy were prospectively recruited. The WSM provided nightly estimations of sleep metrics including AHI, total sleep time, and other non‐apneic metrics over 30‐ and 90‐day periods. MDA integrating treatment efficacy and adjusted compliance was calculated as a composite measure of real‐world treatment effectiveness. Results A total of 29 patients (mean age 59.8 years; 66% male; 93% White) were included, with 15 treated with CPAP and 14 with HGNS. The 90‐day MDA, calculated using continuous AHI monitoring, was 36.05% for CPAP and 24.06% for HGNS ( p = 0.20). Mean MDA using single‐night sleep study (HGNS) or CPAP download (CPAP) was 81.72% (14.81) among CPAP patients and 51.18% (26.69) among HGNS patients ( p = 0.002). HGNS patients experienced more awakenings (3.23 vs. 2.56, p = 0.031) and snoring episodes (2.86 vs. 1.79, p = 0.029) per night during the 30‐day interval. Conclusion This study demonstrates the feasibility of calculating MDA through continuous, non‐invasive home monitoring using the WSA, offering a more comprehensive assessment of OSA treatment effectiveness than single‐night studies alone. These findings support further evaluation of continuous home‐based monitoring and integrated metrics like MDA to inform personalized therapy selection and long‐term management. Level of Evidence 4.
Year:
2026
Objective The effectiveness of hypoglossal nerve stimulation (HGNS) for residual obstructive sleep apnea (OSA) in patients with prior bariatric surgery (BS) has not been previously reported. We evaluate and compare HGNS outcomes in this unique population. Methods We conducted a multi‐institutional retrospective review between 2014 and 2023. Patients with prior BS were compared to those without (nBS). A 1:2 propensity score matching (PSM) was performed using age, gender, race, and baseline BMI. Data collected included demographics, pre/post‐operative apnea‐hypopnea index (AHI), body mass index (BMI), and Epworth Sleepiness Score (ESS). Treatment success was defined using Sher15 criteria. Analyses were conducted in R‐Studio. Results After PSM, 72 patients met inclusion (mean age 61.3 years, 62% male, 83% White), including 24 (33%) with BS. Sher15 response rates were 71% in BS vs. 56% in nBS ( p = 0.2). BS patients had significantly greater mean AHI reductions than NBS (−28.44 ± 16.39 vs. −17.68 ± 21.23; p = 0.009). Both groups had comparable reductions in ESS (−4.67 vs. −3.44; p = 0.2), with a mean postoperative ESS of 6.78 in BS and 6.17 in NBS ( p = 0.5). On multivariable linear regression adjusting for demographics, baseline AHI, and BMI, prior BS was independently associated with greater AHI reduction (β = −8.6; 95% CI −16, −1.1; p = 0.026). Conclusion Patients with prior BS achieve comparable or superior outcomes following HGNS. Prior weight loss may enhance HGNS effectiveness and merits further study. Level of Evidence 3.
Year:
2026
Background Free flap reconstruction (FFR) following transoral robotic surgery (TORS) is commonly performed using radial forearm free flaps (RFFF). This study compares patterns of functional recovery between RFFFs and anterolateral thigh flaps (ALTFs). Methods Retrospective cohort study of patients with oropharyngeal cancer who underwent TORS with FFR (2010–2023) at a tertiary care center. A 1:4 ALTF:RFFF propensity score match was performed. Functional Oral Intake Scale (FOIS) assessed outcomes. Results The 105 patients were included. ALTF patients had lower FOIS at 6 months (3[2.0, 5.0] vs. 5.0[2.0, 6.0], p = 0.045) and 1 year (5.0[2.0, 6.0] vs. 6.0[5.0, 6.8], p = 0.045), with higher PEG tube rates. ALTFs were used for larger defects (62.95 ± 20.25 cm 2 vs. 51.17 ± 15.11 cm 2 , p = 0.014). Donor site morbidity or postoperative complications were similar between cohorts. Conclusions ALTFs are suitable for larger defects and lead to slower early functional recovery with higher PEG tube rates compared to RFFFs, with no difference in complications.
Year:
2025
Background Evidence regarding the indications and survival benefit of adjuvant radiotherapy (aRT) in pT1‐2N0M0 head and neck adenoid cystic carcinoma (HNAdCC) is inconclusive. Lower‐staged, node‐negative HNAdCC therefore represents a rare, moderate‐risk disease category with high variation in adjuvant management depending on patient and physician preferences. Our study investigates the impact of aRT on overall survival (OS) in this rare, moderate‐risk disease category. Methods The 2006 to 2018 National Cancer Database was retrospectively reviewed for patients with pT1‐2N0M0 HNAdCC. Multivariable binary logistic and Cox regression models were implemented. Results Of 738 patients satisfying inclusion criteria, 379 (51.4%) underwent aRT. Oral cavity primary site (aOR 0.64, 95% CI 0.43–0.96) was associated with lower odds of undergoing aRT ( p < 0.05); neck dissection (aOR 1.58, 95% CI 1.09–2.28) and PSM (aOR 1.84, 95% CI 1.30–2.60) were associated with higher odds of undergoing aRT ( p < 0.025). Patients undergoing aRT had higher 5‐year (94% vs. 86%) and 10‐year OS (85% vs. 73%) than those not undergoing aRT ( p < 0.001). Adjusting for patient demographics, pathologic features, and treatment, age at diagnosis (aHR 1.05, 95% CI 1.02–1.08, p < 0.001) was associated with worse OS; aRT (aHR 0.30, 95% CI 0.13–0.69, p = 0.005) was associated with higher OS. Conclusion Approximately half of patients with pT1‐2N0M0 HNAdCC did not undergo aRT, highlighting a possible deviation from evidence‐based recommendations and an opportunity for quality improvement in the multidisciplinary care of patients. aRT was associated with higher 5‐year and 10‐year OS, suggesting that patients with lower‐staged, node‐negative HNAdCC should be offered aRT to optimize long‐term survival. Level of Evidence 4.
Year:
2025
Background Treatment at high-volume facilities (HVF) has been associated with improved prognosis of HNC patients undergoing curative treatment. Whether this systemic factor influences survival outcomes of patients with HNC undergoing palliative treatment is unknown. Aim To investigate the impact of palliative treatment facility volume on overall survival (OS) in patients with head and neck cancer (HNC). Design The 2004 to 2018 National Cancer Database was queried retrospectively for patients with HNC undergoing palliative treatment. Setting/participants Patients were stratified based on treatment facility volume percentile. Multivariable binary logistic and Cox proportional hazards regression models were implemented. Results Of 8682 patients included, 1661 (19.1%) underwent palliative therapy at facilities with volume ≥80 th percentile. Among 972 facilities included, 643 (66.2%), 182 (18.7%), 85 (8.8%), 44 (4.5%), and 18 (1.9%) had volume <20 th , 20-40 th , 40-60 th , 60-80 th , and ≥80 th percentiles, respectively. 5-year OS rates of patients undergoing palliative therapy at facilities with volume <20 th , 20-40 th , 40-60 th , 60-80 th , and ≥80 th percentile was 11%, 13%, 11%, 14%, and 23%, respectively ( P < .001). Facility volume ≥80 th percentile was associated with higher 5-year OS on multivariable Cox regression (aHR 0.34, 95% CI 0.16-0.69, P < .001). Surgical treatment (aOR 1.34, 95% CI 1.07-1.68, P = .012) was associated with undergoing treatment at facilities with volume ≥80 th percentile. Conclusions Undergoing palliative treatment at HVFs is associated with higher OS in HNC. The survival benefit derived from high facility volume should be carefully considered in the context of other patient and facility characteristics in end-of-life management, with specific emphasis on patient-directed goals of care.
Year:
2025
Objective Obesity is a well‐established risk factor for obstructive sleep apnea (OSA), and weight loss is often recommended alongside hypoglossal nerve stimulation (HGNS) in continuous positive airway pressure‐intolerant patients. Our study assesses how long‐term changes in body mass index (BMI) following HGNS impact surgical success. Study Design A retrospective case review. Methods We performed a retrospective case review of OSA patients who underwent HGNS at our institution from 2017 to 2022 and multicenter prospective patient data from the ADHERE registry. Patients were included if they had pre‐ and postoperative sleep studies and BMI data 1 year following surgery, and postsurgical outcomes were evaluated. Patients were stratified into 3 cohorts based on their BMI change from baseline to final follow‐up following surgery: (1) remaining within 2 BMI points, (2) gaining at least 2 BMI points, or (3) losing at least 2 BMI points. Results In both institutional cohort (N = 222) and ADHERE cohort (N = 1949), most of the patients remained within 2 BMI points after HGNS (84.1% and 80.8%, respectively). The patients who lost at least 2 BMI points had the greatest reduction in AHI (−24.77 ± 13.84, −22.58 ± 19.76 events/h) compared to patients who maintained stable BMI (−15.10 ± 20.33, −18.85 ± 18.11 events/h) or gained at least 2+ BMI points (−6.39 ± 22.52, −15.82 ± 19.63 events/h) following HGNS ( P = .002 and .006, respectively). Conclusions While HGNS effectively reduces AHI, this effect was most significant in patients who experienced weight loss compared to those who gained or remained in stable body weight. Our study underscores the importance of postoperative weight management and its adjunctive role in improving HGNS success in OSA patients.
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Collaborators (4)
David Cognetti
department of surgery thomas jefferson university hospital sidney kimmel medical college philadelphia university and tho
Colin Huntley
Thomas Jefferson University
Robert M. Brody
Assistant Professor
University of Pennsylvania
Karthik Rajasekaran
University of Pennsylvania
Make your next move.
Prepare your application
Review drafts before you send them.